Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Chemocentryx Inc patents

Recent patent applications related to Chemocentryx Inc. Chemocentryx Inc is listed as an Agent/Assignee. Note: Chemocentryx Inc may have other listings under different names/spellings. We're not affiliated with Chemocentryx Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Chemocentryx Inc-related inventors




Date Chemocentryx Inc patents (updated weekly) - BOOKMARK this page
07/20/17Method of treating c3 glomerulopathy
07/20/172-oxindole compounds
05/25/17Inhibitors of cxcr2
05/25/17Modulators of chemokine receptors
04/27/17C5ar antagonists
04/06/17Heteroaryl sulfonamides and ccr2/ccr9
03/09/17C5ar antagonists
01/26/17Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
01/26/17Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
11/24/16Ccr2 modulators
11/03/16Substituted anilines as ccr(4) antagonists
10/20/16Diazole lactams
10/13/16Ccr6 compunds
10/13/16Azaindazole compounds and methods of use
08/11/16C5ar antagonists
07/07/16Diazole amides
07/07/16Antagonists of chemokine receptors
06/30/16Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
05/26/16Cxcr7 antagonists
04/07/16Combinations and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of c-c chemokine receptor 9 (ccr9) and anti-alpha4beta7 integrin blocking antibodies
03/31/16Processes and intermediates in the preparation of c5ar antagonists
02/11/16Polymorphic forms of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
02/11/16Polymorphic forms of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
06/25/15Ccr6 compounds
05/21/15Substituted anilines as ccr(4) antagonists
05/21/15C5ar antagonists
03/19/15Aryl sulfonamides
03/12/15Aza-aryl 1h-pyrazol-1-yl benzene sulfonamides
01/15/15N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
06/26/14Diazole amides
06/19/14Diazole lactams
06/19/14Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
06/05/14Cxcr7 antagonists
06/05/14Polymorphic forms of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
05/01/14Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
04/10/14Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
02/27/14Antagonists of chemokine receptors
12/19/13Azaindazole compounds and methods of use
11/28/13C5ar antagonists
10/10/13Aryl sulfonamides
09/12/13Pyrrolidinone carboxamide derivatives
08/29/13Aza-aryl 1h-pyrazol-1-yl benzene sulfonamides
07/18/133-(imidazolyl)-pyrazolo[3,4-b]pyridines
07/11/134-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
07/04/13Substituted anilines as ccr(4) antagonists
06/27/13Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
03/07/13Crystalline form of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
09/27/12N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
06/28/12Triazolyl phenyl benzenesulfonamides
01/12/123-(imidazolyl)-pyrazolo[3,4-b]pyridines
12/29/11Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
11/10/11C5ar antagonists
07/07/11Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
04/28/11Azaindazole compounds and methods of use
04/07/11Pyrrolidinone carboxamide derivatives
03/03/11Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
01/27/11Aryl sulfonamides
01/20/11Modulators of cxcr7
12/30/10N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/09/10Modulators of cxcr7
12/09/10C5ar antagonists
11/04/10Reagents that bind ccx-ckr2
09/30/10Methods and compositions for modulating angiogenesis
09/23/10Substituted piperazines
09/09/10Bis-aryl sulfonamides
Patent Packs
07/29/10Triazolyl phenyl benzenesulfonamides
07/08/103-(imidazolyl)-pyrazolo[3,4-b]pyridines
06/24/10C5ar antagonists
06/17/10Modulators of cxcr7
06/17/10Triazolyl pyridyl benzenesulfonamides
06/10/10Inhibitors of human tumor-expressed ccxckr2
05/06/10Compounds for the treatment of osteoporosis and cancers
03/18/104-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
03/04/10Heteroaryl sulfonamides and ccr2
10/29/09Aryl sulfonamides
10/08/09Azaindazole compounds and methods of use
06/25/09Aryl sulfonamides
05/07/09Aryl sulfonamides
02/26/09Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Chemocentryx Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Chemocentryx Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';